viral
infect
pose
one
major
public
health
threat
time
demonstr
emerg
sarscoronaviru
sarscov
new
pandem
influenza
viru
virus
obligatori
intracellular
pathogen
depend
host
cell
replic
understand
viral
life
cycl
studi
cellular
factor
involv
viral
infect
crucial
identif
new
antivir
target
develop
antivir
drug
viru
entri
first
step
viral
life
cycl
inhibit
essenti
process
attract
approach
block
viru
infect
current
method
studi
viral
entri
host
cell
mostli
reli
postentri
paramet
replic
express
report
gene
rather
measur
entri
per
se
studi
viru
entri
directli
ie
viru
replicationindepend
manner
proven
difficult
certainli
use
low
physiolog
relev
amount
viru
particl
studi
distinct
viru
entri
stage
bind
intern
penetrationfus
varieti
method
appli
radioact
label
structur
viral
compon
electron
microscopi
em
infect
cell
use
investig
viru
bind
intern
radioact
label
structur
viral
compon
mostli
use
methioninelabel
use
mainli
observ
bind
intern
lowph
induc
membran
fusion
addit
requir
handl
radioact
compon
elabor
protocol
techniqu
allow
observ
viru
fusion
directli
studi
viru
infect
em
use
studi
infect
per
se
viral
entri
releas
process
review
well
even
though
em
techniqu
abl
give
visual
insight
viru
entri
includ
variou
stage
entri
process
still
difficult
identifi
cellular
factor
pathway
involv
uptak
process
techniqu
also
em
labor
intens
usual
requir
high
viru
concentr
hardli
suitabl
medium
high
throughput
experi
viru
entri
also
studi
fluoresc
microscopi
fm
either
detect
replicationdepend
viral
protein
reporterfus
protein
express
imag
fluoresc
label
virion
investig
viru
entri
fm
fluoresc
report
protein
express
name
alreadi
indic
requir
viral
replic
process
occur
long
viral
entri
fusion
occur
thu
allow
differenti
entri
replic
eg
way
partial
differenti
process
add
perturb
agent
time
interv
investig
entri
use
fluoresc
label
virion
express
structur
fusion
protein
chemic
label
allow
investig
viru
entri
detail
eg
use
coloc
livecel
microscopi
track
studi
eg
wherea
fm
report
protein
express
experi
may
use
highthroughput
experi
use
wide
varieti
virus
studi
fluoresc
label
virion
labori
requir
high
magnif
resolut
rare
suit
nonenvelop
virus
special
fusion
assay
develop
last
decad
earli
exampl
involv
label
virion
use
selfquench
dye
activ
photosensit
label
virion
fluoresc
lipid
target
membran
howev
assay
sole
allow
investig
fusion
entri
step
complex
difficult
adapt
nonenvelop
virus
recent
enzym
employ
report
viru
entri
incorpor
virion
allow
investig
entri
independ
replic
therefor
either
firefli
gaussia
luciferas
incorpor
structur
lumen
fusion
protein
virion
howev
integr
entir
enzym
sever
hundr
amino
acid
size
sever
affect
viru
assembl
andor
infect
also
fusion
toward
cytosol
may
investig
intact
cell
use
assay
lyse
cell
distinguish
intern
fuse
virion
enzymat
assay
publish
far
except
gaussiatag
vaccinia
viru
mainli
use
fusion
measur
abovement
method
strength
weak
proven
use
lack
assay
distinctli
detect
differ
step
viral
entri
hamper
analysi
import
process
significantli
clear
need
easytous
assay
allow
monitor
viru
penetr
independ
stage
viru
entri
replic
medium
highthroughput
fashion
present
versatil
assay
usabl
differ
format
allow
distinct
analysi
viral
penetrationfus
process
well
bind
intern
viral
particl
replicationindepend
manner
use
minim
enzym
complement
wellstudi
e
coli
enzym
enzym
activ
reconstitut
small
peptid
pair
inact
mutant
form
lack
residu
lacz
repres
aa
lacz
attach
either
c
nterminu
intravirion
viral
protein
express
transient
stabli
cytosol
target
cell
spatial
separ
virion
remov
instanc
viral
cellular
membran
fuse
complement
detect
establish
test
method
two
differ
envelop
virus
murin
hepat
coronaviru
mhv
strain
refer
mhv
belong
coronavirida
vesicular
stomat
viru
vsv
belong
rhabdovirida
coronavirus
cov
plusstrand
rna
virus
infect
varieti
mammal
bird
includ
import
pathogen
sarscov
merscov
caus
sever
respiratori
tract
diseas
human
vsv
negativesens
rna
viru
broad
host
spectrum
rang
mammal
insect
regularli
caus
sever
epidem
livestock
vsv
good
model
viru
new
method
entri
process
well
character
gener
tag
mhv
vsv
virion
use
enzymat
amplif
bind
intern
fusion
virus
could
separ
effici
measur
low
multipl
infect
moi
murin
fibroblast
base
murin
l
cell
orig
atcc
felin
fcwf
atcc
human
atcc
cell
use
propag
virus
ie
recombin
mhv
interspeci
chimer
coronaviru
fmhv
pseudotyp
vsv
respect
cell
maintain
monolay
cultur
dulbecco
modifi
eagl
medium
dmem
lonza
supplement
fetal
calf
serum
fc
stabli
transient
express
cytosol
use
infect
experi
stabl
cell
line
gener
use
moloney
murin
leukemia
mlv
retrovir
vector
mlv
produc
cell
tripl
plasmid
transfect
transfer
vector
contain
gene
well
puromycin
resist
marker
gene
combin
express
vector
encod
mlv
gagpol
vsvg
spike
protein
respect
upon
mlv
transduct
stabli
transduc
cell
select
puromycin
mainten
puromycin
sigma
dmem
supplement
fc
rabbit
polyclon
antisera
vsv
respect
describ
mous
monoclon
antiserum
direct
domain
mhv
fusion
inhibitor
peptid
describ
synthes
genscript
peptid
dilut
trishcl
mm
ph
egta
mm
stock
solut
use
final
concentr
fdg
anaspec
dilut
dmso
stock
solut
mm
purifi
e
coli
sigmaaldrich
dilut
mm
sodium
phosphat
buffer
ph
immedi
prior
use
stock
xgal
sigma
prepar
mgml
dimethyl
sulfoxid
dmso
stock
mm
potassium
ferrocyanid
fe
cn
mm
potassium
ferricyanid
fe
cn
mm
magnesium
chlorid
mgcl
sigma
prepar
water
stock
mm
cycloheximid
chx
sigma
bafilomycin
enzo
life
scienc
mm
dynasor
dyn
enzo
life
scienc
mm
nocodazol
noc
sigma
mm
latrunculin
lata
sigma
mm
jasplakinolid
jasp
sigma
mm
brefeldin
brefa
sigma
prepar
dmso
use
final
concentr
stock
ammonium
chlorid
fluka
mm
chlorpromazin
chlopro
sigma
prepar
use
final
concentr
respect
stock
mm
monensin
mon
sigma
prepar
methanol
meoh
use
final
concentr
cdna
isol
e
coli
field
isol
dna
extract
pcr
cdna
subclon
pcagg
vector
restrictionlig
bamhisbfi
use
gene
isol
e
coli
lab
strain
dna
extract
pcr
gene
clone
pcagg
vector
transient
express
mlvbase
pqcxip
transfer
vector
clontech
gener
stabl
cell
line
restrictionlig
xmainoti
pcagg
smaipaci
pqcxip
transcript
vector
product
donor
rna
target
interspeci
recombin
fmhv
deriv
construct
contain
fusion
gene
made
overlapextens
pcr
clone
parent
vector
restrict
ligat
mluisbfi
xbainhei
result
vector
respect
express
vector
produc
pseudotyp
virus
clone
pcaggsvsvg
vector
overlap
extens
pcr
clone
restrictionlig
sacinoti
recombin
virus
gener
target
rna
recombin
describ
briefli
donor
rna
gener
linear
transfer
vector
describ
electropor
fcwf
cell
infect
interspeci
chimer
fmhv
coronaviru
deriv
ectodomain
spike
replac
spike
ectodomain
felin
coronaviru
therebi
chang
host
cell
tropism
electropor
fcwf
cell
seed
onto
monolay
cell
h
incub
supernat
medium
contain
progeni
virus
harvest
recombin
virus
subject
two
round
plaqu
purif
either
passag
stock
grown
genotyp
recombin
virus
confirm
passag
stock
passag
stock
use
experi
recombin
mhvegfpm
gener
describ
use
transcript
plasmid
pxhegfpm
contain
gfp
express
cassett
e
gene
lack
orf
recombin
pseudoviru
gener
describ
briefli
target
cell
transfect
h
prior
infect
express
cell
inocul
moi
pseudoviru
cell
wash
thoroughli
hpi
hpi
upon
visibl
cytotox
viral
infect
ca
cell
viruscontain
supernat
harvest
procedur
repeat
order
get
rid
residu
pseudoviru
new
viru
stock
virus
store
cultur
medium
supplement
mm
hepe
upon
sucros
cushion
purif
tn
buffer
mm
triscl
ph
mm
nacl
monolay
cell
inocul
virus
appropri
increas
dilut
h
incub
infect
medium
dmem
suppli
fc
inoculum
remov
cell
subsequ
overlaid
mixtur
purifi
agar
sigma
previous
prepar
autoclav
reheat
prior
use
kept
use
emem
gibco
supplement
fc
iuml
penicillin
streptomycin
life
technolog
mm
fe
cn
mm
fe
cn
mm
mgcl
xgal
emem
solut
prewarm
prior
use
infect
overlaid
cell
incub
two
day
recombin
virus
contain
select
base
blue
color
plaqu
gener
virus
blue
cell
plaqu
excis
taken
water
subject
three
freezethaw
cycl
passag
stock
grown
determin
entri
kinet
mhvegfpm
viru
pseudoviru
bound
target
cell
infect
medium
min
moi
wash
ca
cell
got
infect
synchron
infect
unbound
viru
wash
away
icecold
pb
warm
infect
medium
contain
fc
ad
cell
kept
indic
time
point
post
infect
medium
replac
prewarm
infect
medium
viru
infect
allow
progress
hpi
upon
cell
harvest
trypsin
fix
final
concentr
formaldehyd
solut
infect
quantifi
fac
analysi
fac
calibur
benson
dickson
use
flowjo
softwar
event
live
cell
collect
sampl
viru
bound
target
cell
infect
medium
moi
unless
indic
otherwis
synchron
infect
min
synchron
cell
shift
allow
infect
suitabl
amount
time
allow
fusion
occur
stop
viru
degrad
min
vsv
min
mhv
stop
infect
harvest
cell
wash
cold
trypsinedta
gibco
contain
mm
hepe
stop
infect
progress
trypsin
ad
cell
incub
ice
min
cell
resuspend
fc
pb
transfer
cold
ml
eppendorf
tube
cell
collect
centrifug
rcf
min
remov
supernat
resuspend
roomtemperatur
fcspb
immedi
roomtemperatur
fdg
ad
induc
hypoton
shock
enabl
uptak
fdg
substrat
min
cell
rescu
ad
excess
icecold
fcspb
cell
collect
centrifug
rcf
min
follow
remov
supernat
cell
resuspend
icecold
fcspb
transfer
fac
tube
fdg
load
cell
incub
ice
h
unless
otherwis
indic
h
detail
see
fig
file
analyz
fac
prefer
protocol
investig
effect
endocytosi
affect
agent
viral
entri
also
develop
altern
method
preload
cell
fdg
prior
treatment
need
infect
cell
therefor
supernat
adher
target
cell
remov
replac
mixtur
room
temperatur
fcspb
min
incub
roomtemperatur
excess
fcspb
ad
supernat
remov
replac
growth
medium
cell
allow
recov
min
treatment
infect
drug
treatment
etc
undertaken
bind
infect
carri
describ
cell
harvest
h
infect
allow
fluorescein
signal
build
trypsin
trypsinedta
contain
mm
hepe
min
cell
harvest
icecold
fcspb
transfer
eppendorf
tube
collect
centrifug
rcf
min
supernat
remov
cell
resuspend
icecold
fcspb
immedi
analyz
fac
protocol
choic
investig
longlast
agentstreat
sirna
dnca
construct
transfect
adher
cell
microscopi
analysi
cell
may
infect
without
preload
describ
appropri
infect
time
supernat
remov
replac
mixtur
room
temperatur
fcspb
mm
upon
min
incub
roomtemperatur
excess
icecold
fcspb
ad
stop
hypoton
shock
supernat
remov
cell
overlay
icecold
fcspb
sampl
incub
h
cell
allow
recov
flatten
incub
min
analyz
microscopi
cell
analyz
use
evo
invert
fluoresc
microscop
cycloheximid
may
ad
cell
prevent
viral
protein
synthesi
microscopi
analysi
also
compat
preload
protocol
western
blot
viral
structur
protein
virus
purifi
concentr
sucros
tn
buffer
cushion
averag
rcf
pellet
viru
resuspend
tn
buffer
overnight
sd
load
buffer
ad
final
concentr
mm
dtt
boil
min
subject
western
blot
acrylamid
biorad
gel
upon
transfer
nitrocellulos
membran
millipor
viral
protein
probe
antibodi
rabbit
antimhv
pab
g
mous
anti
mab
rabbit
antivsv
pab
respect
blot
develop
use
rabbit
antimous
hrp
swine
antirabbit
hrp
dako
analyz
intracellular
viru
protein
infect
cell
harvest
describ
entri
assay
due
trypsin
treatment
cellbound
viru
remov
intracellular
viru
remain
half
cell
subject
fdg
treatment
activ
measur
wherea
half
mix
sd
load
buffer
subject
western
blot
describ
rabbit
monoclon
abcam
antibodi
use
load
control
detect
viru
bound
target
cell
moi
unless
otherwis
indic
min
bind
assay
unbound
viru
wash
away
icecold
pb
cell
virus
subsequ
lyse
lysi
buffer
mm
trishcl
ph
mm
nacl
supplement
complet
proteas
inhibitor
cocktail
roch
min
roomtemperatur
appropri
amount
lysat
transfer
luminomet
plate
supplement
mm
sodium
phosphat
buffer
ph
transfer
centro
lb
luminomet
berthold
technolog
betaglo
reagent
promega
ad
well
sampl
mix
incub
min
light
unit
measur
second
intern
assay
unbound
viru
wash
away
icecold
pb
short
heat
shock
min
warm
infect
medium
ad
cell
shift
appropri
amount
time
min
vsv
mhv
respect
cell
trypsin
remov
surfac
bound
intern
viru
cell
resuspend
icecold
fcspb
immedi
collect
centrifug
rcf
min
supernat
remov
cell
pellet
resuspend
lysi
buffer
activ
measur
describ
bind
assay
gener
calibr
curv
use
either
purifi
e
coli
dilut
mm
sodium
phosphat
buffer
ph
sucros
cushion
purifi
viru
resuspend
tn
analyz
infect
lyse
lysi
buffer
infect
assay
target
cell
pretreat
drug
indic
min
prior
viru
bind
subsequ
bind
intern
fusion
far
need
respect
assay
carri
presenc
drug
indic
concentr
see
chemic
section
cell
infect
moi
respect
viru
wt
virus
infect
medium
contain
mm
hepe
h
infect
supernat
replac
fresh
infect
medium
infect
allow
progress
period
h
everi
h
small
sampl
supernat
collect
immedi
frozen
supernat
sampl
subsequ
analyz
assay
cell
pseudoviru
purifi
sucros
cushion
describ
viru
prepar
describ
briefli
pellet
viru
resuspend
mm
trishcl
ph
mm
nacl
buffer
mm
mop
ph
mm
nacl
buffer
ph
dissolv
viru
incub
min
subsequ
dialyz
room
temperatur
mm
mop
ph
mm
nacl
buffer
min
viru
prep
ph
ph
adsorb
onto
discharg
carbon
film
subject
neg
stain
uranyl
acet
solut
probe
analyz
philip
microscop
kv
base
minim
complement
devis
three
assay
format
enabl
differenti
analysi
cell
bind
intern
fusion
virus
bind
assay
recombin
virus
contain
intravirion
protein
tag
allow
bind
surfac
target
cell
ice
remov
unbound
viru
amount
bound
viru
particl
quantifi
enzym
complement
upon
lysi
cell
attach
virion
provid
either
express
target
cell
includ
lysi
buffer
complement
detect
use
sequenti
system
substrat
convers
luciferas
gener
luminesc
signal
fig
left
intern
assay
previous
surfacebound
allow
enter
cell
warm
surfacebound
intern
viru
particl
remov
proteas
treatment
eg
trypsin
proteinas
k
ice
prior
lysi
cell
intern
virion
follow
measur
complement
describ
fig
middl
fusion
assay
base
analysi
intact
cell
thu
bound
cell
express
allow
enter
spatial
separ
lift
lysi
fusion
penetr
subsequ
activ
complement
quantit
measur
degrad
nonfluoresc
substrat
fdg
green
fluoresc
fluorophor
fluorescein
fig
right
investig
possibl
consequ
integr
virion
gener
mhv
vsv
deriv
carri
structur
protein
thu
recombin
mhv
obtain
fuse
either
cterminu
spike
protein
nterminu
nucleocapsid
protein
fig
file
pretest
complement
assay
transient
coexpress
tag
protein
protein
cell
confirm
fusion
protein
effici
complement
defect
galactosidas
shown
protein
figur
file
recombin
virus
gener
homolog
target
rna
recombin
growth
properti
affect
slightli
addit
tag
n
protein
impact
growth
seem
mere
delay
growth
decreas
viral
yield
significantli
lower
within
compar
margin
recombin
mhv
virus
modifi
spike
protein
fig
file
analysi
structur
protein
western
blot
show
predict
weight
shift
kda
tag
n
protein
due
larger
size
heterogen
glycosyl
shift
electrophoret
mobil
clearli
visibl
protein
fig
b
genet
ident
recombin
coronavirus
confirm
sequenc
analysi
demonstr
complement
infect
cell
devis
potenti
new
way
select
recombin
mhv
virus
adapt
bluewhit
screen
method
gener
use
select
transform
bacteri
coloni
cell
infect
recombin
viru
overlaid
agarmedium
mixtur
contain
xgal
degrad
xgal
yield
blue
color
precipit
inde
recombin
virus
contain
fusion
protein
gener
blue
plaqu
perform
bluewhit
screen
provid
conveni
way
score
plaqu
assay
eye
simplifi
select
purif
recombin
virus
fig
xgal
appear
harm
target
cell
even
treat
sever
day
allow
us
monitor
plaqu
growth
viral
spread
live
cell
fig
second
model
system
chose
pseudotyp
vsv
describ
tani
et
al
vsv
lack
ggene
genom
complement
ctermin
tag
protein
express
cell
use
produc
pseudotyp
vsv
fig
file
genom
pseudoviru
g
gene
substitut
gene
firefli
luciferas
green
fluoresc
protein
gfp
western
blot
analysi
structur
viru
protein
demonstr
characterist
kda
shift
electrophoret
mobil
protein
due
addit
fig
vsv
pseudotyp
amplifi
similar
titer
wild
type
counterpart
data
shown
incorpor
confirm
em
function
protein
confirm
low
ph
treatment
pseudotyp
particl
result
previous
observ
structur
rearrang
spike
virion
surfac
fig
file
initi
aim
establish
viruscel
fusion
assay
fusion
virus
contain
structur
protein
host
cell
assess
inocul
express
cell
increas
concentr
purifi
concentr
synchron
infect
allow
bind
cell
express
min
ice
unbound
viru
remov
cultur
shift
incub
mhv
min
vsv
base
earlier
studi
viru
entri
kinet
fig
file
incub
stop
cool
cell
cell
detach
ice
fdg
substrat
ad
combin
short
hypoton
shock
result
pinocyt
uptak
fdg
similar
result
obtain
cell
preload
substrat
data
shown
see
method
procedur
prevent
protein
degrad
progress
infect
result
express
new
viral
protein
cell
continu
kept
ice
low
temperatur
slow
enzymat
activ
prolong
incub
requir
obtain
strong
fluorescein
signal
inocul
moi
maximum
fluorescein
signal
reach
h
incub
ice
remain
stabl
h
fig
file
inocul
increas
moi
result
increas
activ
measur
flow
cytometri
cell
densiti
plot
show
maximum
fluoresc
equal
low
high
moi
infect
fig
median
fluoresc
shift
higher
valu
higher
moi
fusion
assay
signific
increas
fluorescein
signal
obtain
alreadi
moi
around
moi
fig
subsequ
fusion
assay
moi
use
stronger
signal
rather
tag
mhv
choic
order
confirm
activ
depend
presenc
cell
assess
correl
intracellular
presenc
tag
protein
fluorescein
signal
therefor
cell
inocul
describ
cell
detach
trypsin
also
remov
cell
surfacebound
virus
cell
analyz
fusion
assay
describ
parallel
sampl
cell
lyse
intracellular
viral
protein
content
determin
immunoblot
n
presenc
intracellular
protein
correl
fluorescein
signal
gener
activ
presenc
protein
synthesi
inhibitor
cycloheximid
chx
signal
peak
min
fig
absenc
chx
signal
level
min
increas
strongli
min
infect
consist
viral
gene
express
fig
similar
result
obtain
fig
file
activ
infect
cell
also
visual
fluoresc
microscopi
cell
inocul
describ
min
post
infect
fdg
ad
cell
sampl
incub
h
ice
analyz
fluoresc
microscopi
infect
min
gener
fluoresc
signal
target
cell
prolong
infect
allow
replicationdepend
increas
level
result
increas
fluoresc
signal
fig
similar
result
obtain
fig
file
bind
intern
carri
virus
assess
assay
cell
express
lyse
viru
bind
intern
allow
complement
initi
character
viru
bind
cell
inocul
increas
concentr
purifi
concentr
cell
overlay
viru
inoculum
min
ice
remov
unbound
viru
cell
virus
lyse
incub
betaglo
substrat
allow
luminesc
readout
activ
incub
min
substrat
room
temperatur
optim
measur
low
activ
data
shown
lysi
buffer
interfer
activ
data
shown
bind
low
moi
alreadi
increas
luciferas
signal
significantli
half
maximum
valu
reach
approxim
moi
plateau
reach
moi
fig
intern
assay
cell
inocul
differ
concentr
purifi
concentr
cell
overlay
viru
inoculum
min
ice
remov
unbound
viru
viru
allow
intern
incub
min
cell
surfac
bound
viru
remov
trypsin
cell
virus
lyse
sampl
incub
betaglo
substrat
activ
measur
describ
half
maximum
valu
reach
fig
standard
allow
quantif
complement
enzym
correspond
viru
particl
fuse
present
upon
lysi
exampl
shown
figur
file
assess
specif
bind
intern
assay
bound
cell
absenc
presenc
antimurin
antibodi
block
entri
receptor
use
mhv
treat
describ
bind
assay
control
cell
surfacebound
viru
remov
use
trypsin
lysi
trypsin
blockag
receptor
dramat
decreas
viru
bind
also
viru
intern
inhibit
receptor
blockag
fig
function
assess
applic
entri
assay
determin
effect
inhibitor
differ
entri
stage
mhv
vsv
prior
inocul
express
target
cell
treat
inhibitori
agent
min
inhibitor
kept
present
throughout
experi
differ
stage
viru
entri
assess
describ
infect
contain
wt
viru
solvent
dimethyl
sulfoxid
dmso
methanol
meoh
includ
control
treatment
cell
chx
affect
bind
intern
fusion
mhv
vsv
inhibit
endosom
matur
ammonium
chlorid
bafilomycin
strongli
reduc
fusion
mhv
vsv
signific
effect
bind
intern
treatment
dynasor
dyn
inhibitor
vesicl
scission
factor
prevent
fusion
virus
partial
affect
intern
influenc
bind
interfer
assembl
clathrinco
vesicl
use
chlorpromazin
chlopro
strongli
decreas
intern
fusion
virus
ionophor
monensin
mon
known
inhibitor
vsv
entri
actin
destabil
agent
latrunculin
lata
lead
reduc
fusion
vsv
mhv
also
affect
intern
virus
fig
articl
present
novel
method
dissect
viral
entri
use
minim
complement
enzym
abl
detect
low
number
viru
particl
stage
entri
process
independ
replic
assay
discrimin
viru
bind
intern
make
possibl
specif
detect
quantifi
viru
particl
underw
fusion
host
cell
measur
viru
fusion
live
cell
allow
quantit
analysi
also
sort
infect
noninfect
cell
therebi
enabl
recultur
cell
also
allow
combin
entri
assay
replicationdepend
report
assay
investig
later
stage
viral
life
cycl
integr
model
virus
feasibl
limit
influenc
viabil
suggest
novel
method
applic
virus
includ
nonenvelop
virus
particularli
latter
virus
proven
difficult
integr
bulki
tag
label
surround
lipid
layer
possibl
gener
everi
viru
shown
possibl
attach
tag
intravirion
structur
protein
good
candid
assay
use
cytosol
express
target
cell
limit
applic
assay
virus
fuse
toward
cytosol
howev
could
chang
express
fusion
protein
fusion
protein
target
compart
unfortun
need
express
target
cell
hamper
investig
fusion
eg
primari
cell
nativ
cell
express
assay
use
investig
bind
intern
suppli
lysi
entri
assay
confirm
extend
current
knowledg
viru
entri
mhv
vsv
use
fusion
assay
confirm
clathrinmedi
endocytosi
vsv
depend
actin
cytoskeleton
interestingli
effect
inhibitori
agent
mhv
entri
similar
vsv
indic
compar
uptak
mechan
virus
treatment
cell
chlorpromazin
caus
clathrin
lattic
redistribut
affect
viru
intern
fusion
vsv
mhv
dynasor
sever
reduc
fusion
mhv
hardli
affect
intern
viru
dynasor
inhibit
endocytosi
inhibit
vesicl
scission
factor
prevent
format
invagin
viral
particl
especi
mhv
comparison
vsv
engulf
complet
endocyt
vesicl
approxim
nm
diamet
trap
invagin
like
much
less
access
remov
trypsin
novel
entri
assay
provid
sever
advantag
convent
assay
use
enzymat
amplif
tag
viral
protein
allow
look
viral
entri
event
independ
gene
express
drug
affect
replic
gener
translat
inhibitor
inadvert
affect
viral
gene
express
test
independ
effect
viru
entri
enzymaticallyamplifi
readout
allow
perform
infect
physiolog
relev
condit
complement
happen
time
proxim
membran
fusion
event
assay
allow
precis
kinet
measur
viru
entri
also
becom
easier
dissect
effect
mutat
virion
entri
andor
replic
furthermor
enzymat
activ
quantifi
varieti
differ
method
open
opportun
highthroughput
analysi
fac
autom
fluoresc
microscopi
fusion
assay
might
improv
use
yet
develop
altern
fdg
substrat
fluorescein
product
photolabil
importantli
demonstr
entri
assay
use
combin
variou
method
perturb
cellular
process
involv
viral
entri
includ
use
inhibitor
rna
interfer
knockout
cell
express
dominantneg
constitutiveact
protein
henc
expect
facilit
research
viru
entri
significantli
